Skip to content

All Press Releases

PILA PHARMA publishes interim report for July 1 – September 30, 2021

Malmö, 26 October, 2021 PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s interim report for the period July – September 2021. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/ SUMMARY OF INTERIM REPORT Nine months (1 January – 30 September 2021) Revenue was SEK  0 (0) Operating loss (EBIT) was SEK - 6 180 (- 1 759) thousand Net…

Read more

Nobel prize for the discovery of PILA PHARMA´s leading principle

Malmö, Sweden, October 5, 202 On Monday, October 4, the Nobel Assembly at Karolinska Institutet announced that the 2021 Nobel prize in Physiology or Medicine goes to the scientists David Julius and Ardem Patapoutian, both active at universities in the USA. The two scientists are jointly rewarded "for their discoveries of receptors for temperature and touch”. One of the receptors…

Read more

Nobelpris till upptäckten av PILA PHARMA:s ledande princip

Malmö, 5 oktober, 2021 På måndagen den 4 oktober meddelande Nobelförsamlingen vid Karolinska Insitutet att 2021 års Nobelpris i fysiologi eller medicin går till David Julius och Ardem Patapoutian, båda vetenskapsmän aktiva vid universitet i USA. De båda tilldelas priset ”för deras upptäckter av receptorer för temperatur och beröring”. En av de receptorer som de hittat är TRPV1-receptorn, som tack…

Read more

Contact us

Subscription for press releases
Back To Top